AzTrials
AzTrials

Parkinson DiseaseNCT06738290

Predicting Motor Learning of an Upper Limb Task Based on Behavioral and Disease-specific Characteristics in Patients With Parkinson's Disease

An observational study of Parkinson Disease, run by KU Leuven at 1 site in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Manual dexterity deficits and loss of motor automaticity are commonly seen in patients with Parkinson's disease (PD). Amongst these problems, using a touchscreen is becoming increasingly burdensome. Read more about this study

Who is it for?
Any age
Conditions the study is for
Parkinson Disease
What is being tested?
Targeted home-based touchscreen training
How many people
100 participants
Where
1 siteBelgium
Study dates
10 Jan 2022to 13 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Recruiting of PD patients will be in collaboration with Prof. Dr. Wim Vandenberghe and Dr. Bruno Bergmans. Patients will receive information about the study after which they can contact the researcher. In addition, our lab has a database with contact information of patients that allowed storages of their information. Moreover, our network of neurologists and physiotherapists across Flanders will be contacted. Finally, our website contains all the information about the ongoing studies. All interested patients will receive detailed information about the aims and procedures of the study before partaking in the study.

Who may be able to join

  • Diagnosis of idiopathic Parkinson's disease based on the criteria of the Movement Disorders Society
  • Right-handed, or right-handed use of touchscreen devices.

Who cannot join

  • Parkinson's disease dementia (PD-D), determined by the level I diagnostics according to Dubois et al. (2007)
  • Comorbidities of the upper limb that could interfere with the study and are not caused by Parkinson's disease
  • Other neurological disorders besides Parkinson's disease
  • Color blindness as determined by the Ishihara test for color deficiency

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • Department of Rehabilitation Sciences KU Leuven

    Leuven, 3001

Other trials in Belgium

About this study

Manual dexterity deficits and loss of motor automaticity are commonly seen in patients with Parkinson's disease (PD). Amongst these problems, using a touchscreen is becoming increasingly burdensome. In addition, a variety of non-motor symptoms, including cognitive impairment have a significant impact on the quality of life of patients with PD which will also affect the use of mobile devices. As the degradation of dopaminergic neurons in the striatum results in an impaired capacity for motor learning and more specifically for consolidation in motor memory, the investigators want to unravel the remaining rehabilitation potential in this patient group. Recent work on the consolidation of an intensive writing training program from our group, indicated inconsistent and variable results on retention of learning gains, which strongly depended on the clinical profile of the patients involved. This raises the question whether it is possible to predict different training responses and better understand how this is determined by clinical characteristics, such as disease severity and the degree of cognitive impairment. Also, baseline task performance and early acquisition may determine long-term learning outcomes. Our main focus (primary dependent outcome) is to know which patients will be able to retain the learning gains after 4 weeks without training. For this aim, the investigators will use a home-based training program of a touchscreen task called the Swipe-Slide Pattern (SSP) task. Training of this SSP-task will be offered on a tablet under single and dual task conditions in a random fashion, not only to provide variation but also to increase the cognitive challenge, thereby stimulating consolidation. A crucial factor, which may affect the success of training, is compliance, which the investigators will measure objectively for the first time. As independent variables the investigators will measure several motor and cognitive functions as well as compliance, while including a broad sample of PD patients.

Read the detailed description

In order to achieve personalised rehabilitation in PD, it is imperative to understand which factors predict whether a patient will benefit from targeted training. To date, only few studies have looked into the predictors of gait and balance training and identified cognitive function at baseline and initial motor performance as the most important determinants. However, these studies focused on global cognitive function, while cognitive subdomains, such as executive function and memory, which are most affected in PD, likely impact more seriously on learning. In addition, patients with cognitive impairments were excluded in these studies. Hence, little is known about how non-motor symptoms, which may also include apathy and depression, interact with the capacity to retain learning in PD.

So far, the determinants of motor learning retention have only been examined as secondary analyses of effect studies in PD. Hence, this study aims to identify predictive factors, including motor and non-motor symptoms, for sustained motor learning in a wide and large PD cohort. The primary dependent outcome is to identify which patients are able to retain the learning gains after 4 weeks without training.

Given the impaired touchscreen skills and the espoused difficulties with retention, training of touchscreen sliding motions will be delivered on a tablet enabling practice in the home setting. Both single (ST) and dual task (DT) conditions will be offered in a random order and feedback will be provided to enhance motivation and retention. This project aims to identify the predictive factors for effect maintenance after receiving this two-week training program. The investigators will recruit a broad cohort of PD patients. Sample size was estimated, using a squared multiple correlation coefficient of 0.17 based on a prediction model from earlier work, which included DT-motor performance and cognitive function as determinants. Using an α = 0.05 and β = 0.20, sample size was calculated for a linear multiple regression: fixed model, R² deviation from 0. Although the number of predictors is dependent on possible multicollinearity, sample size was computed on the assumption of 10 predictors. Sample size was estimated to be 89 and after accounting for a dropout of 20%, 107 patients will have to be included. Importantly, this sample size is also supported by the rule of thumb to include 10 participants per predictor, suggested by Harrell et al. (1996). As the investigators expect to include 10 predictors in our multiple linear regression model (see below), a total number of 100 PD patients will be recruited. The investigators will enroll a wide range of cognitive profiles. However, all patients need to be able to follow instructions and engage in the motor learning. During the instructions of how to perform the touchscreen task, the investigators will assess eligibility pragmatically. The investigators will exclude PD-dementia using level I MDS-diagnostic criteria. All patients will train the SSP-task for a duration of two weeks. On day 1 (T0), all participants will undergo an extensive screening session, including motor and non-motor tests performed at the subject's home or in a quiet room in our laboratory at KU Leuven, according to patients' preference.

The global cognitive screening will consist of the Montreal Cognitive Assessment. Moreover, 2 specific tests will assess each cognitive subdomain. Attention and working memory are captured by the digit and visual span forward and backward test. The trail making and alternating names tests will be used for executive function. Visuospatial function will be examined using the short form of the Benton's judgement of line orientation and the Rey Osterrieth Complex figure. The 30-min recall of the latter test will also be used to assess memory, together with the Rey Auditory Verbal Learning test. The Boston naming test and the Animal fluency test of the Controlled Oral Word Association test will be used to assess language. Other non-motor features, such as anxiety, depression, and sleep quality, will be tested using validated questionnaires for PD. Touchscreen skills will be assessed using the SSP-test in ST and DT condition, the mobile phone task (MPT, typing a predefined telephone number on a smartphone) and specific questionnaires. Following the baseline session, all patients will receive 10 training sessions of the SSP-task randomly in ST and DT condition (2 weeks, 5 days/week, 10 min/session) over a period of two weeks. The training is home-based and unsupervised. Both immediately after training (T1) and after a four-week retention period (T2), touchscreen skills will be assessed at home. To account for performance bias due to other training, other rehabilitation content will be recorded.

For model selection, the investigators will follow the recommendation of the PROBAST tool and reduce the number of cognitive tests accordingly. Other independent variables may include age, gender, disease duration, the New Freezing of Gait Questionnaire, and LEDD. The investigators will also calculate a measure of early acquisition. After exploratory univariate analysis, the investigators expect to include 10 independent variables, taking multicollinearity into account.

Additionally, the investigators will study the determinants of compliance and its association with retention, as compliance with unsupervised home-based training is likely to be associated with specific non-motor characteristics. Apathy and the anticipation of reward have been shown to determine the level of effort generated for exercise in PD unlike in HC. Also, one previous study investigated the relationship between the success of a balance training program and compliance in PD, establishing compliance to be one of the two most important determinants. Other work revealed that disease duration was found to be related to the degree of motor learning of the SSP-task and to exercise adherence altogether. Hence, compliance is likely associated with training outcomes in PD (long- and short-term) and may be modulated by (multiple) clinical characteristics. Compliance will be automatically logged by the digitized system and stored in a secured data cloud. Training compliance will be expressed as a percentage of the desired number of sessions and personalized time, with a maximum of 100%. The investigators will analyze the relation between compliance and clinical characteristics first with a multiple linear regression model. Next, a multiple mediation model will be constructed to examine the expected mediating influence of the clinical profiles on this association. Different models will be applied for retention of learning and immediate training effects, as well as for the different outcome measures.

Being tested
Targeted home-based touchscreen training
Keywords
Neurologic rehabilitation, Motor learning, Touchscreen skills, Personalization
Medical subject headings
Parkinson Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Targeted home-based touchscreen trainingBehavioural

    Participants will practice the Swipe-Slide Pattern (SSP) task independently at home in both ST and DT condition, offered in a random order. During this task, participants perform different pre-defined patterns by moving their finger over a touchscreen, resembling a touchscreen unlock trace. The DT condition includes the SSP-task while counting either red or green lights illuminated on the screen. They will receive 10 training sessions of the SSP-task over a period of two weeks. Each week will consist of 5 consecutive days of training for approximately 10 min. per session. Participants will perform 9 trials of 12 patterns each, alternated with rest periods of 14s. Instruction and answers are also included. Feedback will be provided during the rest periods.

Study groups in NCT06738290
Study groupRoleWhat they receive
Parkinson's diseaseOnly one cohort will be observed. All participants have been diagnosed with Parkinson's disease, according to the criteria of the Movement Disorders Society by a movement disorders specialist. Other eligibility criteria are described below.
Receives: Behavioral: Targeted home-based touchscreen training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Overall learning effects of training on the average slide duration in ST condition

    Using the behavioral data gathered at the different time points (described in Time frame), the changes in average slide duration in ST condition will be determined and used in a multiple linear regression model as dependent variable.

    Measured: Baseline and retention (4 weeks)

Secondary outcomes (6)
  1. Immediate training effects and retention of training on performance accuracy in ST condition

    Using the behavioral data gathered at the different time points (described in Time frame), the immediate changes and overall changes in performance accuracy (in %) will be determined and used in a multiple linear regression model as dependent variable.

    Measured: Baseline, post (2 weeks) and retention (4 weeks)

  2. Immediate training effects and retention of training of the average slide duration in ST condition

    Using the behavioral data gathered at the different time points (described in Time frame), the changes in average slide duration in ST condition will be determined and used in a multiple linear regression model as dependent variable.

    Measured: Baseline, post (2 weeks) and retention (4 weeks)

  3. Immediate and retained training effects and overall learning of the average slide duration in DT condition

    Using the behavioral data gathered at the different time points (described in Time frame), the immediate changes and overall changes in average slide duration in DT condition will be determined and used in a multiple linear regression model as dependent variable.

    Measured: Baseline, post (2 weeks) and retention (4 weeks)

  4. Immediate and retained training effects and overall learning on performance accuracy in DT condition

    Using the behavioral data gathered at the different time points (described in Time frame), the immediate changes and overall changes in performance accuracy (in %) will be determined and used in a multiple linear regression model as dependent variable.

    Measured: Baseline, post (2 weeks) and retention (4 weeks)

  5. Transfer of learning towards an untrained Mobile Phone Task

    Using the behavioral data gathered at the different time points (described in Time frame), changes in the performance on an untrained mobile phone task will be determined, based on the time necessary to type in telephone numbers (in sec) and used in a multiple linear regression model as dependent variable.

    Measured: Baseline, post (2 weeks) and retention (4 weeks)

  6. Compliance rate to training (in %)

    The automatically logged compliance rate will be expressed as the percentage of the desired number of sessions and personalized time (max. 100%). Compliance rate will be used as dependent variable in a multiple linear regression model and in a secondary mediation model.

    Measured: Baseline, post (2 weeks) and retention (4 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Dec 2024
  2. Study start10 Jan 2022
  3. Primary completion12 Dec 2024
  4. Study completion13 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06738290
Sponsor's protocol ID
B3222020000322
Status last verified
Dec 2024
First submitted
12 Dec 2024
Last updated
3 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Parkinson Disease, run by KU Leuven at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Overall learning effects of training on the average slide duration in ST condition (time frame: Baseline and retention (4 weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT06738290 | AzTrials